Market Cap 99.38B
Revenue (ttm) 372.81B
Net Income (ttm) 4.61B
EPS (ttm) N/A
PE Ratio 11.63
Forward PE 11.98
Profit Margin 1.24%
Debt to Equity Ratio 0.90
Volume 6,305,200
Avg Vol 7,713,758
Day's Range N/A - N/A
Shares Out 1.27B
Stochastic %K 48%
Beta 0.48
Analysts Strong Sell
Price Target $94.22

Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPs and Medicaid health care management serv...

Industry: Healthcare Plans
Sector: Healthcare
Phone: 401 765 1500
Fax: 401 652 0893
Address:
One CVS Drive, Woonsocket, United States
BerniePellicone1002
BerniePellicone1002 Dec. 18 at 3:17 PM
$LULU $SBUX $ICE $CVS Market Focus: Analysts' target prices released today have become the focus of attention.
0 · Reply
SherylMcgill673
SherylMcgill673 Dec. 18 at 2:05 PM
$LULU $SBUX $ICE $CVS Market Focus: Analysts' target prices released today have become the focus of attention.
0 · Reply
Doris_Brown
Doris_Brown Dec. 18 at 1:35 PM
$CVS Healthcare execution and vertical integration keeping CVS supported in defensive rotations
0 · Reply
DD_First
DD_First Dec. 18 at 1:26 PM
0 · Reply
JarvisFlow
JarvisFlow Dec. 17 at 7:20 PM
JP Morgan updates rating for CVS Health ( $CVS ) to Overweight, target set at 93 → 101.
0 · Reply
ZacksResearch
ZacksResearch Dec. 17 at 5:11 PM
Health insurers are back in the driver’s seat — and 2026 could be the payoff 🩺📈 Pricing control and margin visibility are improving, putting $UNH, $CVS, and $CNC back in focus as managed care regains its pulse and investor attention. See why these three insurers are lining up as 2026 plays 👉 https://www.zacks.com/stock/news/2805506/health-insurers-now-get-a-pulse-3-stocks-to-jump-in-2026?cid=sm-stocktwits-2-2805506-teaser-25196&ADID=SYND_STOCKTWITS_TWEET_2_2805506_TEASER_25196
0 · Reply
Gigatheta
Gigatheta Dec. 17 at 4:15 PM
$CVS no real buyers No hedge funds want this 200+ PE ratio No real assets Corner store crash out 2028 $15 SHARE PRICE TARGET
1 · Reply
Gigatheta
Gigatheta Dec. 17 at 3:19 PM
$SPY noobs getting crushed Short UVXY LONG SVIX SHORT $CVS
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 17 at 2:10 AM
Actionable Trade Alert for $CVS: Market Context: $CVS is currently trading at $78.07, positioned between its 60-day high of $85.15 and low of $73.83. The RSI at 48.93 indicates a neutral momentum, suggesting potential for upward movement as it approaches oversold levels. Directional Bias: The price is slightly below the 30-day moving average (MA30) of $78.28 and the 50-day moving average (MA50) of $78.98, indicating a potential bullish reversal if it breaks above these levels. Trade Plan: - Suggested Entry: $78.50 (above MA30) - Stop Loss: $76.50 (below recent support) - Take Profit Targets: 1. $81.00 (target 1, approx. 3.2% gain) 2. $83.00 (target 2, approx. 5.9% gain) 3. $91.50 (target 3, approx. 17.2% gain) This plan offers a favorable risk-reward ratio, capitalizing on potential upward momentum while managing risk effectively. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
parcha
parcha Dec. 17 at 12:16 AM
Final Trade: ETH, GM, CVS, NFLX $ETH $GM $CVS $NFLX https://www.cnbc.com/video/2025/12/16/final-trade-eth-gm-cvs-nflx.html?__source=iosappshare%7Ccom.stocktwits.StockTwits.STShareExtension
0 · Reply
Latest News on CVS
Final Trade: ETH, GM, CVS, NFLX

Dec 16, 2025, 6:21 PM EST - 1 day ago

Final Trade: ETH, GM, CVS, NFLX

GM NFLX ETH


Cramer's Stop Trading: CVS Health

Dec 10, 2025, 10:36 AM EST - 7 days ago

Cramer's Stop Trading: CVS Health


Buy Or Fear CVS Stock At $78?

Dec 10, 2025, 9:00 AM EST - 8 days ago

Buy Or Fear CVS Stock At $78?


Cramer's Mad Dash --- CVS Health

Dec 9, 2025, 9:48 AM EST - 9 days ago

Cramer's Mad Dash --- CVS Health


CVS to pay $37.8 million to settle claims over insulin pens

Dec 2, 2025, 10:14 AM EST - 15 days ago

CVS to pay $37.8 million to settle claims over insulin pens


Harrow: Vevye Replaces Xiidra On Tier 1 Formulary At CVS

Dec 1, 2025, 8:00 AM EST - 17 days ago

Harrow: Vevye Replaces Xiidra On Tier 1 Formulary At CVS


These outperforming stocks are still cheap heading into 2026

Nov 27, 2025, 2:15 PM EST - 20 days ago

These outperforming stocks are still cheap heading into 2026

MU NEM


Curaechoice Selects CVS Caremark at its PBM

Nov 24, 2025, 10:58 AM EST - 23 days ago

Curaechoice Selects CVS Caremark at its PBM


CVS Health Names David Joyner Chair of the Board of Directors

Nov 20, 2025, 4:05 PM EST - 27 days ago

CVS Health Names David Joyner Chair of the Board of Directors


Aetna Launches Leading Edge Conversational AI Navigation

Nov 18, 2025, 11:00 AM EST - 4 weeks ago

Aetna Launches Leading Edge Conversational AI Navigation


CVS Health to hold Investor Day on December 9, 2025

Nov 10, 2025, 9:00 AM EST - 5 weeks ago

CVS Health to hold Investor Day on December 9, 2025


CVS Health: Undervalued And Ripe For Growth

Nov 3, 2025, 8:00 AM EST - 6 weeks ago

CVS Health: Undervalued And Ripe For Growth


CVS Health Corporation (CVS) Q3 2025 Earnings Call Transcript

Oct 29, 2025, 10:21 AM EDT - 7 weeks ago

CVS Health Corporation (CVS) Q3 2025 Earnings Call Transcript


CVS Posts Loss on Write-Down, Boosts Guidance

Oct 29, 2025, 6:42 AM EDT - 7 weeks ago

CVS Posts Loss on Write-Down, Boosts Guidance


BerniePellicone1002
BerniePellicone1002 Dec. 18 at 3:17 PM
$LULU $SBUX $ICE $CVS Market Focus: Analysts' target prices released today have become the focus of attention.
0 · Reply
SherylMcgill673
SherylMcgill673 Dec. 18 at 2:05 PM
$LULU $SBUX $ICE $CVS Market Focus: Analysts' target prices released today have become the focus of attention.
0 · Reply
Doris_Brown
Doris_Brown Dec. 18 at 1:35 PM
$CVS Healthcare execution and vertical integration keeping CVS supported in defensive rotations
0 · Reply
DD_First
DD_First Dec. 18 at 1:26 PM
0 · Reply
JarvisFlow
JarvisFlow Dec. 17 at 7:20 PM
JP Morgan updates rating for CVS Health ( $CVS ) to Overweight, target set at 93 → 101.
0 · Reply
ZacksResearch
ZacksResearch Dec. 17 at 5:11 PM
Health insurers are back in the driver’s seat — and 2026 could be the payoff 🩺📈 Pricing control and margin visibility are improving, putting $UNH, $CVS, and $CNC back in focus as managed care regains its pulse and investor attention. See why these three insurers are lining up as 2026 plays 👉 https://www.zacks.com/stock/news/2805506/health-insurers-now-get-a-pulse-3-stocks-to-jump-in-2026?cid=sm-stocktwits-2-2805506-teaser-25196&ADID=SYND_STOCKTWITS_TWEET_2_2805506_TEASER_25196
0 · Reply
Gigatheta
Gigatheta Dec. 17 at 4:15 PM
$CVS no real buyers No hedge funds want this 200+ PE ratio No real assets Corner store crash out 2028 $15 SHARE PRICE TARGET
1 · Reply
Gigatheta
Gigatheta Dec. 17 at 3:19 PM
$SPY noobs getting crushed Short UVXY LONG SVIX SHORT $CVS
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 17 at 2:10 AM
Actionable Trade Alert for $CVS: Market Context: $CVS is currently trading at $78.07, positioned between its 60-day high of $85.15 and low of $73.83. The RSI at 48.93 indicates a neutral momentum, suggesting potential for upward movement as it approaches oversold levels. Directional Bias: The price is slightly below the 30-day moving average (MA30) of $78.28 and the 50-day moving average (MA50) of $78.98, indicating a potential bullish reversal if it breaks above these levels. Trade Plan: - Suggested Entry: $78.50 (above MA30) - Stop Loss: $76.50 (below recent support) - Take Profit Targets: 1. $81.00 (target 1, approx. 3.2% gain) 2. $83.00 (target 2, approx. 5.9% gain) 3. $91.50 (target 3, approx. 17.2% gain) This plan offers a favorable risk-reward ratio, capitalizing on potential upward momentum while managing risk effectively. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
parcha
parcha Dec. 17 at 12:16 AM
Final Trade: ETH, GM, CVS, NFLX $ETH $GM $CVS $NFLX https://www.cnbc.com/video/2025/12/16/final-trade-eth-gm-cvs-nflx.html?__source=iosappshare%7Ccom.stocktwits.StockTwits.STShareExtension
0 · Reply
SimpleWinningSetups
SimpleWinningSetups Dec. 16 at 7:46 PM
Hedge Alert Live - Protect Your Portfolio Contract: $CVS $77.00 Put · DEC 26, 2025 Exp Entry Price: $0.80 - $0.87 Exit Price Target: $1.79 Profit Margin: +124% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
Doris_Brown
Doris_Brown Dec. 16 at 5:56 PM
$CVS defensive cash-flow narrative gaining attention as healthcare rotation quietly builds
0 · Reply
DD_First
DD_First Dec. 16 at 3:50 PM
0 · Reply
BillionerOfKing
BillionerOfKing Dec. 16 at 12:51 PM
$CVS Current Stock Price: $79.70 Contracts to trade: $80 CVS Dec 19 2025 Call Entry: $0.85 Exit: $1.23 ROI: 44% Hold ~29 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
thegreatkaspi
thegreatkaspi Dec. 15 at 6:52 PM
0 · Reply
DD_First
DD_First Dec. 15 at 4:28 PM
0 · Reply
OptionsTrackX_1540
OptionsTrackX_1540 Dec. 15 at 3:52 PM
$CVS healthcare retail, defensive base, trend confirmation if it holds higher lows into earnings
0 · Reply
ZacksResearch
ZacksResearch Dec. 15 at 2:19 PM
$CVS on the rise after announcing MMR vaccinations in SC! 🚀 📈 Shares up 2.4% post-announcement 💡 Pharmacy segment’s revenue grew 12% year over year in Q3 2025 🔍 Estimated 22.7% earnings growth rate for 2025 Discover more about CVS's latest moves and potential impacts on stock performance! https://www.zacks.com/stock/news/2804294/cvs-stock-gains-from-offering-mmr-vaccine-to-south-carolina-residents?cid=sm-stocktwits-2-2804294-body-24758&ADID=SYND_STOCKTWITS_TWEET_2_2804294_BODY_24758
0 · Reply
KingdomTrading
KingdomTrading Dec. 15 at 1:30 PM
$CVS Price: 79.42 Entry: 76.89 Exit: 74.68 Duration: 14D Disclaimer: The content provided on https://www.ztradez.net is for informational purposes only and does not constitute a recommendation to buy or sell any security.
0 · Reply
ZacksResearch
ZacksResearch Dec. 15 at 1:19 PM
$CVS catching a health-driven bid — and it’s not random 🚨 CVS Health shares jumped after the company began offering MMR vaccines across South Carolina pharmacies and clinics following a measles outbreak. See how this public health move is impacting the stock 👉 https://www.zacks.com/stock/news/2804294/cvs-stock-gains-from-offering-mmr-vaccine-to-south-carolina-residents?cid=sm-stocktwits-2-2804294-teaser-24757&ADID=SYND_STOCKTWITS_TWEET_2_2804294_TEASER_24757
0 · Reply
AlmostMiddleClass
AlmostMiddleClass Dec. 15 at 9:35 AM
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 15 at 5:43 AM
Actionable Trade Alert for $CVS: Market Context: $CVS closed at $79.42, showing a stable position within the recent 60-day high of $85.15 and low of $73.80. The RSI at 53.99 indicates a neutral stance, suggesting potential for upward movement without being overbought. Directional Bias: The price is above the 30-day MA of $78.24 and the 50-day MA of $78.91, indicating bullish momentum. The proximity to the 60-day high suggests a breakout potential. Trade Plan: - Suggested Entry: $79.50 (slightly above the last close for confirmation) - Stop Loss: $77.50 (to limit downside risk) - Take Profit Targets: 1. Target 1: $82.00 (approx. 3.14% gain) 2. Target 2: $84.00 (approx. 5.68% gain) 3. Target 3: $93.00 (approx. 17.14% gain) This trade plan leverages the current bullish sentiment and market structure, aiming for a significant ROI on the third target. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply